PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
- Status
- RECRUITING
- Phase
- N/A
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Oncological and Functional Outcomes of Laparoscopic Partial Nephrectomy in Renal Cell Carcinoma Stages T1 Versus T2a: Prospective Comparative Study.
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
- Status
- UNKNOWN
- Phase
- PHASE1
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona
- Status
- WITHDRAWN
- Phase
- NA
ITIL-306 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
- Status
- COMPLETED
- Phase
- N/A
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
- Status
- RECRUITING
- Phase
- PHASE2
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1